Evidence map›Paper›PMID 40755165›Full record

ArticleInternational journal of language & communication disorders

Prediction of Speech Impairment in Patients Treated for Oral or Oropharyngeal Cancer Using Automatic Speech Analysis.

Mathieu Balaguer, Julien Pinquier, Jérôme Farinas, Virginie Woisard

Abstract read
In one paragraph

Article in International journal of language & communication disorders. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mathieu BalaguerIRIT, Université de Toulouse, CNRS, Toulouse INP, UT3, Toulouse, France.ORCID https://orcid.org/0000-0003-1311-4501
Julien PinquierIRIT, Université de Toulouse, CNRS, Toulouse INP, UT3, Toulouse, France.ORCID https://orcid.org/0000-0003-1556-1284
Jérôme FarinasIRIT, Université de Toulouse, CNRS, Toulouse INP, UT3, Toulouse, France.ORCID https://orcid.org/0000-0002-7456-9019
Virginie WoisardHôpital Larrey, Hôpital de Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-3895-2827

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPerceptual evaluation of speech disorders produces scores that poorly predict the consequences of speech impairment on the communication abilities of patients treated for oral/oropharyngeal cancer. This may be mitigated by automatic speech analysis.

aimTo measure communication and speech impairment using automatic analyses of spontaneous speech and self-administered questionnaires in patients treated for oral cavity or oropharyngeal cancer. METHODS AND PROCEDURES: The spontaneous speech of 25 patients was recorded during a semistructured interview. Various acoustic and automatic tools were applied to the speech signal to obtain scores relating to the different linguistic levels. Reduction of dimensionality was applied to retain only relevant and nonredundant parameters. Self-administered questionnaires assessing communication and associated factors (associated deficits, anxiety/depression, cognitive status, communication needs relating to social circles, self-perception of speech impairment and quality of life) were conducted. A predictive modelling of communication and speech impairment by LASSO regression was performed using the scores from the automatic tools alone, which were then combined with the scores arising from the questionnaires. OUTCOMES AND

resultsA total of 149 automatic parameters were extracted from the speech signal, of which 75 were retained after dimensional reduction. Predictive modelling of communication and speech impairment [Holistic Communication Score (HoCoS)] using the selected automatic parameters (number of sonants and occlusives recognised per second) provides a correlation of 0.83 between the predicted and actual score. This modelling is reliable (r CONCLUSIONS AND IMPLICATIONS: The use of automatic speech analysis allows a reliable prediction of the communication and speech impairment experienced by the patients. This study opens up new perspectives for the use of automatic speech recognition systems in clinical evaluation and for the consideration of functional and psychosocial needs expressed by the patients during their follow-up. WHAT THIS PAPER ADDS: What is already known on the subject Automatic and acoustic analyses compensate for the biases of perceptual speech assessment in clinical practice. Although they are used to assess speech severity, few studies have examined their contribution to the measurement of communication and speech impairment, which is yet an essential objective of clinical intervention. What this paper adds to the existing knowledge Acoustic and automatic analyses (and in particular the use of automatic speech recognition systems) enable good prediction of communication and speech impairment reported by patients, with a limited number of tools and parameters. This prediction is even improved by adding to the models scores from self-questionnaires measuring functional and psychosocial dimensions that may be impacted by the speech disorder. This study provides reliable new tools for measuring impaired communication. What are the potential or actual clinical implications of this work? Acoustic and automatic tools can be used in routine clinical care to obtain a valid and reliable measure of communication and speech impairment. This prediction leads to a follow-up score to quantify the level of communication and speech impairment at a given time and the evolution of patients from a speech sample.

Indexed as

Mouth NeoplasmsOropharyngeal NeoplasmsSpeech DisordersSpeech Production MeasurementAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPredictive Value of TestsQuality of LifeSurveys and Questionnairesautomatic assessmentcommunicationoncologyspeech disorder

Identifiers

PMID40755165
PMCPMC12319489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.